Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2018 Filed Jun 14, 2018 20:49 UTC |
Kennard William EDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037760 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,413.919 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:47 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037758 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,792.7597 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:46 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalents · Derivative | 526.4266 | $47.49 | $25,000.00 |
DisclosureSEC source: 0001209191-18-037755 · doc4.xml · derivative · entry 3 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526.4266 Underlying: Common Stock · 526.4266 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:46 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037755 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,150.0988 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:44 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037753 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,441.4805 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:43 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037751 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,008.2642 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:42 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037749 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,832 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:41 UTC |
Herzog David LDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037748 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,883 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:39 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock Equivalent Units · Derivative | 315.856 | $47.49 | $15,000.00 |
DisclosureSEC source: 0001209191-18-037745 · doc4.xml · derivative · entry 4 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315.856 Underlying: Common Stock · 315.856 shares Expires not disclosed F4 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F5 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F4 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:39 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037745 · doc4.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,808 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:39 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037744 · doc4.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,273 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:38 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037742 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,089.8216 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| May 09, 2018 Filed May 10, 2018 20:22 UTC |
HASSELL GERALD LDirector
|
PurchaseCommon Stock | 10,000 | $46.18 | $461,800.00 |
DisclosureSEC source: 0001209191-18-029253 · doc4.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,018 F1 · price: The price reported is the weighted average price of the aggregate number of shares purchased in multiple open market transactions. The shares were purchased at prices $46.175 to $46.19, inclusive. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:29 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023664 · doc4.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,042 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:26 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023652 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,651.4805 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:27 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023655 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,218.2642 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:25 UTC |
Kennard William EDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023644 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,623.919 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:25 UTC |
KELLY ALFRED F JRDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023641 · doc4.xml · nonDerivative · entry 1 KELLY ALFRED F JR · CIK 0001209454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,997.943 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:24 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023638 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,002.7597 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:23 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalent Units · Derivative | 555.3088 | $45.02 | $25,000.00 |
DisclosureSEC source: 0001209191-18-023636 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555.3088 Underlying: Common Stock · 555.3088 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:23 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023636 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,360.0988 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:23 UTC |
Herzog David LDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023635 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,093 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:23 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock Equivalent Units · Derivative | 333.1853 | $45.02 | $15,000.00 |
DisclosureSEC source: 0001209191-18-023633 · doc4.xml · derivative · entry 3 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333.1853 Underlying: Common Stock · 333.1853 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: The Reporting Person acquired these Common Stock Equivalent Units pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:23 UTC |
HASSELL GERALD LDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023633 · doc4.xml · nonDerivative · entry 1 HASSELL GERALD L · CIK 0001209482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:22 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023630 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,299.8216 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:22 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023632 · doc4.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,483 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:20 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 215.0169 | $47.10 | $10,127.30 |
DisclosureSEC source: 0001209191-18-019836 · doc4.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,385.2642 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:19 UTC |
Kennard William EDirector
|
GrantCommon Stock | 124.5551 | $47.10 | $5,866.55 |
DisclosureSEC source: 0001209191-18-019833 · doc4.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,790.919 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:19 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock Equivalent Units · Derivative | 94.0586 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019835 · doc4.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94.0586 Underlying: Common Stock · 94.0586 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:19 UTC |
KILTS JAMES MDirector
|
GrantCommon Stock | 397.5619 | $47.10 | $18,725.17 |
DisclosureSEC source: 0001209191-18-019835 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,818.4805 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:18 UTC |
KELLY ALFRED F JRDirector
|
GrantCommon Stock | 249.8605 | $47.10 | $11,768.43 |
DisclosureSEC source: 0001209191-18-019831 · doc4.xml · nonDerivative · entry 1 KELLY ALFRED F JR · CIK 0001209454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,164.943 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:18 UTC |
KELLY EDWARD J IIIDirector
|
GrantCommon Stock | 85.6401 | $47.10 | $4,033.65 |
DisclosureSEC source: 0001209191-18-019829 · doc4.xml · nonDerivative · entry 1 KELLY EDWARD J III · CIK 0001160225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,169.7597 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:17 UTC |
KANDARIAN STEVEN ADirector · Chairman, President & CEO
|
GrantCommon Stock | 1,350.0632 | $47.10 | $63,587.98 |
DisclosureSEC source: 0001209191-18-019827 · doc4.xml · nonDerivative · entry 1 KANDARIAN STEVEN A · CIK 0001255728 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,273.016 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:17 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock Equivalents · Derivative | 157.5955 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019825 · doc4.xml · derivative · entry 2 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157.5955 Underlying: Common Stock · 157.5955 shares Expires not disclosed F2 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · kind: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F2 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F2 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:17 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 343.1503 | $47.10 | $16,162.38 |
DisclosureSEC source: 0001209191-18-019825 · doc4.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,527.0988 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:16 UTC |
GRISE CHERYL WDirector
|
GrantCommon Stock | 393.7585 | $47.10 | $18,546.03 |
DisclosureSEC source: 0001209191-18-019824 · doc4.xml · nonDerivative · entry 1 GRISE CHERYL W · CIK 0001192342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,466.8216 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantRestricted Stock Units · Derivative | 9,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · derivative · entry 13 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,891 Underlying: Common Stock · 9,891 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F12 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. F12 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 29,664 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · derivative · entry 12 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,664 Underlying: Common Stock · 29,664 shares Expires 2028-03-01 F11 · derivative.exercise_date: The options become exercisable in three installments on March 2, 2019, 2020 and 2021. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · derivative · entry 11 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,894 Underlying: Common Stock · 4,447 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F9 · shares: Includes 474 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F10 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F10 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2018, 2019 and 2020. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F9 · derivative.underlying_shares: Includes 474 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · derivative · entry 10 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,070 Underlying: Common Stock · 6,070 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F7 · shares: Includes 648 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F8 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F8 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2017, 2018 and 2019. The requisite certification that MetLife, Inc. met specified financial goals took place earlier. F7 · derivative.underlying_shares: Includes 648 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · derivative · entry 9 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,631 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F5 · shares: Includes 388 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. F6 · derivative.exercise_date: The Restricted Stock Units vest in three installments on February 24, 2016, 2017 and 2018. This installment became payable following the certification on March 2, 2018 that MetLife, Inc. met specified financial goals. F6 · derivative.expiration_date: The Restricted Stock Units vest in three installments on February 24, 2016, 2017 and 2018. This installment became payable following the certification on March 2, 2018 that MetLife, Inc. met specified financial goals. F5 · derivative.underlying_shares: Includes 388 Restricted Stock Units previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the Restricted Stock Units in light of the distribution by MetLife, Inc., to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the Restricted Stock Units. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Tax withholdingCommon Stock | 3,793 | $45.50 | $172,581.50 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · nonDerivative · entry 8 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,543 F4 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Performance Share payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
GrantCommon Stock | 10,085 | $45.50 | $458,867.50 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · nonDerivative · entry 7 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,336 F3 · kind: Shares acquired from the payout of 2015-2017 Performance Share Award pursuant to the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Tax withholdingCommon Stock | 1,524 | $45.50 | $69,342.00 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · nonDerivative · entry 6 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,251 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionCommon Stock | 4,447 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · nonDerivative · entry 5 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Tax withholdingCommon Stock | 2,079 | $45.50 | $94,594.50 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · nonDerivative · entry 4 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,328 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionCommon Stock | 6,070 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · nonDerivative · entry 3 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Tax withholdingCommon Stock | 1,231 | $45.50 | $56,010.50 |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · nonDerivative · entry 2 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,337 F2 · kind: Shares withheld to satisfy the Reporting Person's tax withholding obligation due on the Restricted Share Unit payout. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:49 UTC |
Goulart Steven JEVP & Chief Investment Officer
|
Exercise / conversionCommon Stock | 3,631 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-017320 · doc4.xml · nonDerivative · entry 1 Goulart Steven J · CIK 0001519833 · EVP & Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:42 UTC |
TADROS RAMYEVP & Chief Risk Officer
|
GrantRestricted Stock Units · Derivative | 1,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017304 · doc4.xml · derivative · entry 2 TADROS RAMY · CIK 0001714199 · EVP & Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,979 Underlying: Common Stock · 1,979 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. F3 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.